Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
SrVP/CFO/Prin Fin & Acct Ofcr
-
Stock Symbol
-
APRE on Nasdaq
John Hamill - trading volume in the past year for Aprea Therapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
22.7K |
$89K |
$3.92 |
Mar 27, 2025 |
Direct |
|
|
| Stock Options (Right to Buy) |
13.5K |
|
|
Mar 27, 2025 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.